High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models.

Yost SE, Pastorino S, Rozenzhak S, Smith EN, Chao YS, Jiang P, Kesari S, Frazer KA, Harismendy O. High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models. PLoS One. 2013; 8(2):e56185.

View in: PubMed

subject areas

Animals
Brain Neoplasms
Cluster Analysis
Disease Models, Animal
Glioblastoma
Humans
Mice
Mutation
Oligonucleotide Array Sequence Analysis
Polymorphism, Single Nucleotide
Reproducibility of Results
Transplantation, Heterologous

authors with profiles

Sandra Pastorino, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support